The Mid-Cycle Transition Over the past month, we’ve taken a different path than most equity strategists. Rather than getting excited about the reopening, we are getting more concerned about (1) execution risk and (2) what’s already priced in.First, on the execution front, there’s growing evidence that supply remains a problem for many companies, just as demand is picking up. These…
Morgan Stanley: Sunday Start | What’s Next in Global Macro
A financial market resource for the every-day investor and trader.
-
Merrill Lynch 2021 Outlook
Seth Golden, , Research Reports, 0
OVERVIEW Following on our series that was produced this year called “The Book of Great,” which discussed 10 separate...
-
A Flattening Yield Curve, Tech Earnings and GDP Await Investors
Seth Golden, , Research Reports, 0
The prior week for equity investors and the major averages was shaping up to be a strong week that...
-
Sentiment, Leverage, Is it Early 2018 Again or…?
Seth Golden, , Research Reports, 0
Please click the following link to review our commentary on Sentiment, Leverage, Is it Early 2018 Again or…? What...
-
For Many, This Is An Uncomfortably Strong Market
Seth Golden, , Research Reports, 2
If there is 1 thing I’ve learned from the markets over my 23 years, it’s that down is going...
-
Analysis and Updates From Wall Street
Seth Golden, , Research Reports, 0
Capital Economics We think the 10-year Treasury yield will end the year well below its current level. The sell-off in...
-
Will spending take a post vacation break?
Seth Golden, , Research Reports, 0
Key talking points Bank of America aggregated credit and debit card spending was up 11% year-over-year (YoY) in June....
-
Pantheon Macro: U.S. Economic Monitor
Seth Golden, , Research Reports, 0
Stepping back from the January noise, the trends in core economic activity data are discouraging. It’s unrealistic to think...
-
VIX-ETP Core Holding Update: Golden Capital Portfolio Management
Seth Golden, , Research Reports, 2
Today, as part of the Golden Capital Portfolio holdings update, I will be adjusting capital exposure minimally with iPath S&P...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00